GNMSF - Janssen submits Type II variation application to EMA March, 22 2019 07:35 AM Genmab A/S Dkk Genmab A/S (OTCPK:GNMSF) announces that Janssen Pharmaceutica NV has submitted a Type II variation application to the EMA.More news on: Genmab A/S, Genmab A/S, Healthcare stocks news, Read more ...